Hematologic cancers are those cancers that occur in cells of the immune system or in blood-forming tissues, including bone marrow. As a pioneer in advancing care for all hematologic cancers and related blood disorders, City of Hope's Hematologic Malignancies and Stem Cell Transplantation Institute leads the field as one of the largest and most successful transplant centers in the world.
Led by Stephen J. Forman, M.D., Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, our dedicated, multidisciplinary team combines innovative research discoveries with superior clinical treatments to improve outcomes for patients with:
Leukemia (cancer of the blood cells) at the Gehr Family Center for Leukemia Research
Acute lymphoblastic leukemia
Chronic myelogenous leukemia
Chronic lymphocytic leukemia
Myeloma (cancer of plasma cells) at the Judy and Bernard Briskin Center for Multiple Myeloma Research
Myelodysplastic Syndrome (blood abnormalities that can be life-threatening or lead to cancer)
Other hematologic disorders
In addition to the named centers above, the institute also houses the Center for Gene Therapy, the Center for Stem Cell Transplantation, the Survivorship Center and the Center for T Cell Transplantation, all focused on discovering and improving treatments against hematologic disorders.
If you have been diagnosed with a hematologic cancer or are looking for a second opinion consultation about your treatment, request an appointment online or contact us at 800-826-HOPE. Please visit Making Your First Appointment for more information.